KRISTA WARNAKULA: Open Payments
NPI 1801530977 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 62 payments from 9 companies in 2025. Trend: 2023 $419 · 2024 $290 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 23 | $331 |
| Lilly USA, LLC | 10 | $243 |
| Incyte Corporation | 21 | $232 |
| GENZYME CORPORATION | 2 | $33 |
| Arcutis Biotherapeutics, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $16 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $15 |
| Organon LLC | 2 | $9 |
Products named: NEMLUVIO, Opzelura, EBGLYSS, TALTZ, DUPIXENT, JAKAFI, Zoryve, TREMFYA.
Industry payments across NM — which companies pay providers there.
